Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ.
Studer
U E
UE
Department of Urology, University of Bern, Switzerland.
Casanova
G
G
Kraft
R
R
Zingg
E J
EJ
D000368:Aged; D000369:Aged, 80 and over; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000628:therapy*; D010478:Chemotherapy, Cancer, Regional Perfusion; D006801:Humans; D008297:Male; D009403:Nephrostomy, Percutaneous; D014516:Ureteral Neoplasms / Q000628:therapy*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine